Erin O’Shea Named Vice President and Chief Scientific Officer at HHMI

News   Dec 03, 2012

 
Erin O’Shea Named Vice President and Chief Scientific Officer at HHMI
 
 
 

RELATED ARTICLES

Cancer Gene Plays Key Role in Cystic Fibrosis Lung Infections

News

Recent findings explain why people with cystic fibrosis are particularly prone to respiratory infections—and suggest a new approach to treatment.

READ MORE

Exploring African Genetic Diversity Unlocks Disease Susceptibility Traits

News

African populations harbour the greatest genetic diversity and have the highest per capita health burden, yet they are rarely included in large genome studies of disease association, the authors of this study want to change this fact.

READ MORE

Agent Reverses Resistance to Targeted Drug in Some Leukemias

News

After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE